What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?

Kabacam G., TÖRÜNER M.

TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.21, sa.1, ss.107-112, 2010 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 21 Sayı: 1
  • Basım Tarihi: 2010
  • Doi Numarası: 10.4318/tjg.2010.0066
  • Dergi Adı: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.107-112
  • Anahtar Kelimeler: Crohn's disease, luminal Crohn's disease, anti-TNF therapy, NECROSIS-FACTOR-ALPHA, MONOCLONAL-ANTIBODY, MAINTENANCE TREATMENT, DOUBLE-BLIND, INFLIXIMAB, ADALIMUMAB, THERAPY, REMISSION, MANAGEMENT, INDUCTION
  • Ankara Üniversitesi Adresli: Evet